ChromaDex (CDXC) Reports In-Line Q2 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/14/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
ChromaDex Corporation Reports Second Quarter 2021 Financial Results
August 3, 2021 4:02 PM EDTTru Niagen® net sales of $15.4 million for the three months ended June 30, 2021, up 31% from the prior year quarter, with total company net sales of $17.7 million and gross margin of 61.1% for the quarter.
LOS ANGELES--(BUSINESS WIRE)-- ChromaDex Corp. (NASDAQ: CDXC) today announced financial results for the second quarter of 2021.
Second Quarter 2021 and Recent Highlights
Total net sales were $17.7 million, up 16% from the prior year quarter. Tru Niagen® net sales were $15.4 million, a 31% increase from the prior year quarter. Gross... More